Athenex, Inc.: Nasdaq/NYSE listing notice — Athenex receives Nasdaq delisting notice for failure to meet minimum market value of publicly held shares

Athenex, Inc.

Received letter from Nasdaq on Apr 27, 2023 for non-compliance with min market value of publicly held shares (<$15M).
180-day compliance period until Oct 24, 2023 to regain compliance by maintaining $15M+ for 10 consecutive business days.
If non-compliance persists, Nasdaq will delist ATNX common stock; Company can appeal to hearings panel.
No immediate effect on listing; Company considering options to address the deficiency.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

Athenex, Inc. received a nasdaq deficiency notice notice regarding market value (rules 5450(b)(3)(C), 5810(c)(3)(D)).

Exchange: nasdaq
Notice: deficiency notice
Deficiency: market value
Rules: 5450(b)(3)(C), 5810(c)(3)(D)

Exact text from the filing

April 27, 2023, Athenex, Inc. (the “Company”) received a letter from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) indicating that, based upon the closing bid price of the Company’s common stock for the last 30 consecutive business days and its number of publicly held shares, the Company no longer meets Nasdaq Listing Rule 5450(b)(3)(C), which requires listed companies to maintain a minimum market value of publicly held shares of at least $15 million. Nasdaq Listing Rule 5810(c)(3)(D) provides a compliance period of 180 calendar days, or until October 24, 2023, in

View on SEC.gov

Browse all listing & compliance notices →

Source: SEC EDGAR

accession 0001193125-23-134421

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.